MACHINE LEARNING-BASED CLASSIFICATION OF

BRAIN TUMOR FROM MR IMAGES

Brain tumors pose a substantial public health issue due to their varied classifications and
varying degrees of aggressiveness. The importance of prompt and precise diagnosis cannot be
overstated, as it is essential for the development of effective treatment strategies and the
enhancement of patient outcomes. Magnetic Resonance Imaging (MRI) is a commonly
employed imaging technique that offers exceptional soft tissue contrast, making it highly
effective in the identification and characterization of brain tumors. The issue at hand pertains
to the improvement of both efficiency and accuracy in the classification of brain tumors
through the utilization of machine learning methodologies applied to MRI data. The problems
encompass several factors, such as the intricate nature of tumor heterogeneity, the
requirement for extensive data processing on a wide scale, and the incorporation of
sophisticated algorithms to provide reliable classification. In the conventional diagnostic
procedure, radiologists conduct a visual analysis of MRI scans, utilizing their expertise and
understanding to detect and classify malignancies. The aforementioned technique possesses
an inherent subjectivity and susceptibility to external influences, including but not limited to
fatigue and inter-observer variability. Hence, the necessity for automated brain tumor
categorization arises due to the constraints associated with manual interpretation, which can
be both time-consuming and subjective. Machine learning (ML) methodologies present the
opportunity to achieve expedited and uniform analysis, hence enabling prompt identification
and accurate categorization. Furthermore, the utilization of ML techniques for the purpose of
classifying brain tumors based on MRI images signifies a significant transformation within
the realm of diagnostic radiology. The relevance of this technology is in its capacity to
enhance accuracy, efficiency, and objectivity, hence leading to improved patient outcomes in
the management of brain tumors.